Krsnaa Diagnostics Ltd Stock Price Today (NSE: KRSNAA)

Krsnaa Diagnostics Ltd

544.70+3.10 (+0.57%)
Market Open

Fundamental Score

...

Krsnaa Diagnostics Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Krsnaa Diagnostics Ltd share price today is 544.70, up +0.57% on NSE/BSE as of 22 June 2026. Krsnaa Diagnostics Ltd (KRSNAA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of 2.63K (Cr). The 52-week high for KRSNAA share price is 894.40 and the 52-week low is 515.00. At a P/E ratio of 30.73x, KRSNAA is currently trading below its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 9.29% and a debt-to-equity ratio of 0.30.

Krsnaa Diagnostics Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
622.55
Low
536.10
Volume
89.8K
Change
-10.27%

Krsnaa Diagnostics Ltd share price chart: -10.27% return over the past month. 52-week high ₹894.40, 52-week low ₹515.00.

Krsnaa Diagnostics Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
541.60549.85536.00544.7037.82K (Cr)
550.00555.00540.00541.6055.24K (Cr)
546.50563.00533.00549.451.96L (Cr)
544.60552.25536.10538.451.60L (Cr)
622.55622.55541.20548.955.26L (Cr)
567.10575.70547.05553.8565.63K (Cr)
562.45568.95560.35562.5535.42K (Cr)
562.80569.95560.00561.9032.98K (Cr)
563.00570.00561.00562.8019.35K (Cr)
565.00572.95562.00566.3021.09K (Cr)

Krsnaa Diagnostics Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
550.00555.00536.00544.70-0.96%
597.75622.55533.00549.45-8.08%
530.00630.35530.00588.75+11.08%
629.70637.90515.00520.30-17.37%
695.35733.10621.00635.45-8.61%
715.00775.00692.85712.10-0.41%
804.00817.40703.00721.35-10.28%
770.05838.00716.15810.75+5.29%
758.00848.10754.95776.70+2.47%
788.70894.40752.00756.80-4.04%
861.40875.00781.05788.70-8.44%
709.00875.00693.80861.40+21.50%

Returns & Performance

Poor

Return on Equity (ROE)

9.29%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

12.52%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

26.91%

Average operating profit margin over 5 years

Dividend Yield

0.34%

Annual dividend as % of current share price

Krsnaa Diagnostics Ltd Valuation Check

Good

Price to Earnings (P/E)

30.73x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

39.28x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

27.11%

% shares held by company founders/management

Poor

FII Holding

3.66%

% shares held by foreign institutional investors

Good

DII Holding

14.96%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

5.78%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

2.33%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

21.41%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

16.14%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

22.05%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.30x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

5.20x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-202.11 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Krsnaa Diagnostics Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KRSNAA across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Strong Operating Margins (26.91%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 30.73 vs Industry: 39.28)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (21.41% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (16.14% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (22.05% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.30)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (5.20x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Below-Average Return on Equity (9.29%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Negative Free Cash Flow (₹-202.11 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (27.11%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

Krsnaa Diagnostics Ltd vs Healthcare Service Provider Peers

Peer Comparison - Healthcare Service Provider

Compare Krsnaa Diagnostics Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
39.6/100
545
₹2626.09
30.7
Average
9.29%
Poor
12.52%
Average
0.3
Excellent
22.05%
Excellent
21.41%
Excellent
0.34%
64.3/100
1617
₹25557.40
47.8
Average
24.30%
Excellent
28.88%
Excellent
0.1
Excellent
16.69%
Excellent
13.09%
Good
0.79%
53.7/100
1261
₹10272.45
67.4
Average
19.00%
Good
20.91%
Excellent
0.4
Excellent
18.97%
Excellent
15.00%
Excellent
0.20%
48.9/100
536
₹10124.28
64.0
Average
11.53%
Average
14.66%
Average
0.1
Excellent
-0.56%
Poor
9.22%
Good
0.20%
40.5/100
512
₹7724.80
60.5
Average
16.15%
Good
24.78%
Excellent
0.1
Excellent
-0.64%
Poor
9.62%
Good
1.44%
47.1/100
290
₹1534.08
48.0
Average
16.46%
Good
17.84%
Good
0.5
Good
16.38%
Excellent
9.86%
Good
0.00%
66.1/100
1225
₹1080.56
22.0
Average
19.40%
Good
25.75%
Excellent
0.0
Excellent
44.03%
Excellent
27.29%
Excellent
0.32%
69.5/100
424
₹1070.08
24.4
Average
42.31%
Excellent
56.38%
Excellent
0.0
Excellent
128.82%
Excellent
0.00%
40.3/100
314
₹1042.27
4.63%
Poor
-1.33%
Poor
0.0
Excellent
23.31%
Excellent
24.47%
Excellent
0.00%
46.5/100
234
₹826.72
30.5
Average
27.08%
Excellent
28.85%
Excellent
0.5
Excellent
0.00%
45.3/100
126
₹92.81
55.9
Average
6.63%
Poor
9.20%
Poor
1.2
Average
32.13%
Excellent
8.21%
Good
0.00%

Krsnaa Diagnostics Ltd PE Ratio History

Historical price-to-earnings ratio for KRSNAA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202523.56₹721.3530.6x
FY 202417.31₹885.5051.2x
FY 202319.29₹706.0036.6x
FY 202222.88₹460.9020.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Krsnaa Diagnostics Ltd Dividend History

Annual cash dividends paid by KRSNAA — dividend yield 0.34%

Financial YearDividends Paid (₹ Cr)
FY 20258.07 Cr
FY 20248.63 Cr
FY 20237.85 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Krsnaa Diagnostics Ltd Quarterly Performance

Latest quarterly metrics for KRSNAA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

2.33%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

5.78%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

21.41%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

22.05%

Compounded annual net profit growth over 5 years

Krsnaa Diagnostics Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KRSNAA — calculated from daily price history

10RSI 14
Oversold — RSI 10

Selling pressure is heavy — potential reversal zone.

SMA 50
585
▼ Price below SMA 50 — Short-term bearish
SMA 200
717
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
78K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Krsnaa Diagnostics Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Krsnaa Diagnostics Ltd (KRSNAA) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Krsnaa Diagnostics Ltd

About KRSNAA (Krsnaa Diagnostics Ltd)

Krsnaa Diagnostics Ltd is a prominent healthcare service provider in India, dedicated to delivering accessible and reliable diagnostic solutions. The company functions as a compreh...ensive diagnostic center, providing a broad spectrum of services encompassing both radiology and pathology. Its radiology offerings feature advanced imaging modalities such as computed tomography (CT) scans, magnetic resonance imaging (MRI), X-rays, and ultrasounds, catering to diverse diagnostic requirements. Alongside its imaging capabilities, Krsnaa Diagnostics provides a comprehensive suite of pathology services, incorporating extensive laboratory testing, convenient home sample collection, and preventive health checkups. Beyond its core diagnostic services, Krsnaa Diagnostics leverages technology to extend its reach and enhance service delivery through teleradiology and telepathology. These remote consultation and diagnostic reporting services enable timely access to expert interpretations, particularly in underserved areas. The company's commitment to innovation is further exemplified by its provision of specialized diagnostic services, including ophthalmic tests, mammography, dental imaging, stress tests, and dual-energy X-ray absorptiometry (DEXA) scans. This multifaceted approach underscores Krsnaa Diagnostics' dedication to offering a complete diagnostic solution to patients and healthcare providers alike. Krsnaa Diagnostics prides itself on its unwavering commitment to quality, accuracy, and patient-centric care. By combining state-of-the-art technology, a highly skilled team of medical professionals, and a widespread network of diagnostic centers, the company strives to empower individuals with the knowledge necessary to make informed healthcare decisions. Krsnaa Diagnostics focuses on expanding its geographical footprint and broadening its service offerings to address the evolving healthcare needs of the Indian population. Through its unwavering dedication to excellence, Krsnaa Diagnostics plays a crucial role in improving the overall health and well-being of the communities it serves.

Company Details

Symbol:KRSNAA
Industry:Healthcare Service Provider
Sector:Healthcare Service Provider

Key Leadership

Mr. Rajendra Khivraj Mutha
Executive Chairman
Mr. Mitesh Dave
Group Chief Executive Officer
Mr. Pawan Daga C.A.
Chief Financial Officer

KRSNAA Share Price: Frequently Asked Questions

What is the current share price of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd (KRSNAA) trades at ₹544.70 on NSE and BSE. Market cap ₹2.63K (Cr). Educational data only.

What is the P/E ratio of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd has a P/E of 30.73x vs industry average 39.28x.

What is the Bull Run score for Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd has a Bull Run score of 39.6/100 based on 25+ financial parameters.

Does Krsnaa Diagnostics Ltd pay dividends?

Krsnaa Diagnostics Ltd has a dividend yield of 0.34%. Past dividends don't guarantee future payments.

What is the ROE of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd has ROE of 9.29%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Krsnaa Diagnostics Ltd?

Krsnaa Diagnostics Ltd has debt-to-equity of 0.30.

Is Krsnaa Diagnostics Ltd a good investment?

Bull Run gives Krsnaa Diagnostics Ltd a score of 39.6/100. This is not investment advice — consult a SEBI-registered advisor.